We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Accuray (ARAY) Inks Cancer Treatment Technology Delivery Deal
Read MoreHide Full Article
Accuray Incorporated (ARAY - Free Report) recently inked a deal with DHL Supply Chain that will further boost Accuray’s aftermarket supply chain and help in expansion of its superior quality customer service worldwide. This global service parts logistics partnership will become effective starting February 2021.
In order to lend support to Accuray, DHL Supply Chain will build a dedicated global service logistics network spaninng across 34 warehousing sites in 16 countries. This will help the service technicians at Accuray to enhance reliability and visibility on parts related to its advanced radiotherapy systems.
This deal further highlights Accuray’s commitment to expanding its portfolio of collaborations.
Benefits of the Partnership
The primary objective of the partnership is to offer medical care teams with uninterrupted access to the radiotherapy technologies required to deliver shorter, customized and effective treatments to patients with cancerous or benign tumors or neurologic disorders.
Collaborating with a world class logistics partner like DHL will help Accuray in leveraging DHL’s superior capabilities and help the supply chain and service teams to provide seamless access to its lifesaving equipment. With rise in demand for Accuray technology and products, DHL will serve as a standardized logistics platform, thereby enabling the company to get the flexibility and reliability to quickly cater to their international clients’ service needs.
Recent Development
In October 2020, Accuray inked a collaboration deal with Brainlab, a Germany-based market leader in digital surgery and precision radiotherapy. This will improve and broaden the Accuray CyberKnife treatment platform for the neuro-radiosurgery market. The companies are partnering to offer neuro-radiosurgery community access to Brainlab Elements planning software, which will provide contouring capabilities optimized for neurosurgeons.
Price Performance
Shares of the Zacks Rank #2 (Buy) company have gained 48.6% in a year’s time, compared to the industry’s rally of 13.6%.
Cardinal Health has a projected long-term earnings growth rate of 5.4%.
Align Technology has an estimated long-term earnings growth rate of 18.3%.
Thermo Fisher has a projected long-term earnings growth rate of 18%.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Accuray (ARAY) Inks Cancer Treatment Technology Delivery Deal
Accuray Incorporated (ARAY - Free Report) recently inked a deal with DHL Supply Chain that will further boost Accuray’s aftermarket supply chain and help in expansion of its superior quality customer service worldwide. This global service parts logistics partnership will become effective starting February 2021.
In order to lend support to Accuray, DHL Supply Chain will build a dedicated global service logistics network spaninng across 34 warehousing sites in 16 countries. This will help the service technicians at Accuray to enhance reliability and visibility on parts related to its advanced radiotherapy systems.
This deal further highlights Accuray’s commitment to expanding its portfolio of collaborations.
Benefits of the Partnership
The primary objective of the partnership is to offer medical care teams with uninterrupted access to the radiotherapy technologies required to deliver shorter, customized and effective treatments to patients with cancerous or benign tumors or neurologic disorders.
Collaborating with a world class logistics partner like DHL will help Accuray in leveraging DHL’s superior capabilities and help the supply chain and service teams to provide seamless access to its lifesaving equipment. With rise in demand for Accuray technology and products, DHL will serve as a standardized logistics platform, thereby enabling the company to get the flexibility and reliability to quickly cater to their international clients’ service needs.
Recent Development
In October 2020, Accuray inked a collaboration deal with Brainlab, a Germany-based market leader in digital surgery and precision radiotherapy. This will improve and broaden the Accuray CyberKnife treatment platform for the neuro-radiosurgery market. The companies are partnering to offer neuro-radiosurgery community access to Brainlab Elements planning software, which will provide contouring capabilities optimized for neurosurgeons.
Price Performance
Shares of the Zacks Rank #2 (Buy) company have gained 48.6% in a year’s time, compared to the industry’s rally of 13.6%.
Other Stocks to Consider
Some other top-ranked stocks from the broader medical space include Cardinal Health Inc. (CAH - Free Report) , Align Technology, Inc. (ALGN - Free Report) and Thermo Fisher Scientific Inc. (TMO - Free Report) , each carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Cardinal Health has a projected long-term earnings growth rate of 5.4%.
Align Technology has an estimated long-term earnings growth rate of 18.3%.
Thermo Fisher has a projected long-term earnings growth rate of 18%.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>